Glycogen phosphorylase: A novel biomarker in doxorubicin-induced cardiac injury

Yueming Zhu, David Gius*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Extracellular vesicles containing glycogen phosphorylase, brain/heart (PYGB) have been demonstrated as a sensitive biomarker for normal cardiac injuries for patients after chemotherapy. Oxidative stress was suggested to be the mechanism behind the chemotherapy-induced tissue damage and augmented with mitochondrial antioxidant could be an effective means of early intervention.

Original languageEnglish (US)
Pages (from-to)1516-1517
Number of pages2
JournalClinical Cancer Research
Volume24
Issue number7
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Glycogen phosphorylase: A novel biomarker in doxorubicin-induced cardiac injury'. Together they form a unique fingerprint.

  • Cite this